News

National Peroxide announced that the Board of Directors of the Company at its meeting held on 30 April 2026, inter alia, have recommended the final dividend of Rs 7 per equity Share (i.e. 70%) , subject to the approval of the shareholders.

Net profit of National Peroxide reported to Rs 7.93 crore in the quarter ended March 2026 as against net loss of Rs 6.49 crore during the previous quarter ended March 2025. Sales rose 16.26% to Rs 85.68 crore in the quarter ended March 2026 as against Rs 73.70 crore during the previous quarter ended March 2025.For the full year,net profit reported to Rs 11.04 crore in the year ended March 2026 as against net loss of Rs 2.25 crore during the previous year ended March 2025. Sales rose 0.99% to Rs 289.71 crore in the year ended March 2026 as against Rs 286.87 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales85.6873.70 16 289.71286.87 1 OPM %17.38-3.19 -10.775.30 - PBDT15.95-2.74 LP 35.8118.03 99 PBT10.67-7.82 LP 15.02-2.08 LP NP7.93-6.49 LP 11.04-2.25 LP Powered by Capital Market - Live News

National Peroxide will hold a meeting of the Board of Directors of the Company on 30 April 2026.

Net profit of National Peroxide reported to Rs 1.83 crore in the quarter ended December 2025 as against net loss of Rs 1.52 crore during the previous quarter ended December 2024. Sales rose 11.15% to Rs 69.09 crore in the quarter ended December 2025 as against Rs 62.16 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales69.0962.16 11 OPM %10.125.18 - PBDT7.573.19 137 PBT2.36-2.00 LP NP1.83-1.52 LP Powered by Capital Market - Live News

National Peroxide has revised the meeting of the Board of Directors which was scheduled to be held on 28 January 2026. The meeting will now be held on a later date.Powered by Capital Market - Live News